Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Donna Bannavong"'
Autor:
Erica Browning, Erika J. Crosby, Takuya Osada, Bernard A. Fox, Carlo Bifulco, Jendy Sell, Irene Wapnir, Melinda L. Telli, Kaitlin Zablotsky, Reneta Hermiz, Kellie Malloy Foerter, Robert H. Pierce, Chaitanya R. Acharya, Kim Jaffe, Donna Bannavong, Mai Hope Le, H. Kim Lyerly, Shawn M. Jensen, Carmen Ballesteros-Merino, David A. Canton, Christopher G. Twitty, Hiroshi Nagata, Lauren Svenson
Publikováno v:
Clin Cancer Res
Purpose: Triple-negative breast cancer (TNBC) is an aggressive disease with limited therapeutic options. Antibodies targeting programmed cell death protein 1 (PD-1)/PD-1 ligand 1 (PD-L1) have entered the therapeutic landscape in TNBC, but only a mino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c48e8953fa4ba2b471eaae121c3944b
https://europepmc.org/articles/PMC8102331/
https://europepmc.org/articles/PMC8102331/
Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma
Autor:
Mai Le, Shailender Bhatia, Carmen Ballesteros-Merino, Adil Daud, Murray Francisco, Christopher G. Twitty, Erica Browning, Reneta Hermiz, Mikael J. Pittet, Arielle Oglesby, Sharron Gargosky, Katy K. Tsai, Christopher Garris, Lawrence Fong, Michael Rosenblum, Bernard A. Fox, Robert H.I. Andtbacka, David A. Canton, Alain Algazi, Carlos Bifulco, Lauren P. Levine, Donna Bannavong, Sean P. Arlauckas, Robert H. Pierce
Publikováno v:
BASE-Bielefeld Academic Search Engine
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 26, iss 12
Clin Cancer Res
Clinical Cancer Research, Vol. 26, No 12 (2020) pp. 2827-2837
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 26, iss 12
Clin Cancer Res
Clinical Cancer Research, Vol. 26, No 12 (2020) pp. 2827-2837
Purpose: Tumors with low frequencies of checkpoint positive tumor-infiltrating lymphocytes (cpTIL) have a low likelihood of response to PD-1 blockade. We conducted a prospective multicenter phase II trial of intratumoral plasmid IL-12 (tavokinogene t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38d86693cc71daf5a3684a1122cd1bce
https://escholarship.org/uc/item/59t2b8v3
https://escholarship.org/uc/item/59t2b8v3